Clinical trial

Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary…

NCT00156793 · Acusphere, Industry · Completed

Key facts

NCT number NCT00156793
Title Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging
Official title A Phase 3, International, Multicenter, Open Label, Dual-Injection, Echocardiographic Imaging and Safety Study of AI-700 in Patients With Suspected Ischemic Heart Disease Undergoing Single-Photon Emission Computed Tomography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 1)
Lead sponsor Acusphere, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Procedure
Interventions AI-700 contrast-enhanced echocardiography
Enrollment 400
Start date Dec 1, 2003
Completion Mar 1, 2006
First posted Sep 12, 2005
Last update posted Jul 14, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies